The DOI matches its Crossref record.
Interleukin-1 Plus γ-Interferon-Induced Pancreatic β-Cell Dysfunction Is Mediated by β-Cell Nitric Oxide Production
Abstract
Cytokines have been implicated in pancreatic β-cell destruction leading to type 1 diabetes. In vitro, a combination of γ-interferon (IFN-γ) and interleukin-1 (IL-1) stimulate inducible nitric oxide synthase (iNOS) expression in islets, and the resulting increased production of nitric oxide (NO) causes islet cell destruction. Islets contain macrophages, ductal cells, and endothelial cells that, when activated, may mediate islet cell damage by producing either NO themselves or cytokines that then stimulate NO production by β-cells. The aim of this study was to determine whether β-cell damage mediated by cytokine-induced NO production is dependent on β-cell production of NO, or whether NO produced by other cells in the islet is capable of destroying β-cells. To address this aim, we used transgenic mice expressing a dominant-negative IFN-γ receptor in β-cells (RIP-ΔγR). RIP-ΔγR islets are resistant to IL-1 + IFN-γ-induced inhibition of insulin secretion and DNA damage, indicating that β-cell IFN-γ responsiveness is required for IL-1 + IFN-γ-mediated β-cell damage. Although islets isolated from RIP-ΔγR mice are resistant to functional damage, these islets produce NO in response to IL-1 + IFN-γ, but at a lower concentration than that produced by wild-type islets. β-Cells appear to be the primary cellular source of IL-1 + IFN-γ-induced iNOS expression in wild-type islets. In contrast, IL-1 + IFN-γ fail to stimulate iNOS expression by insulin-expressing cells in islets isolated from RIP-ΔγR mice. IL-1 + IFN-γ-induced expression of iNOS was detected in non-β-cells in both wild-type and RIP-ΔγR islets. These findings support the hypothesis that NO must be produced by β-cells to induce damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
NLRP3 at the interface of metabolism and inflammation
Haneklaus, M., & O'Neill, L. A. J. (2015) · Immunological Reviews · doi:10.1111/imr.12285 · Cited by 294
Causes of limited survival of microencapsulated pancreatic islet grafts
de Groot, M., Schuurs, T. A., & van Schilfgaarde, R. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.02.018 · Cited by 170
Chapter 4 CD8+ T Cells in Type 1 Diabetes
Tsai, S., Shameli, A., & Santamaria, P. (2008) · Advances in Immunology · doi:10.1016/s0065-2776(08)00804-3 · Cited by 140
Farnsworth, N. L., Walter, R. L., Hemmati, A., Westacott, M. J., & Benninger, R. K. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679506 · Cited by 48
Metadata
- Authors
- Thomas, H. E., Darwiche, R., Corbett, J. A., & Kay, T. W. H.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-02-01
- Volume
- 51
- Issue
- 2
- Pages
- 311-316
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2088400959
- Cited by
- 164
- References
- 0
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin-1 Plus γ-Interferon-Induced Pancreatic β-Cell Dysfunction Is Mediated by β-Cell Nitric Oxide Production. https://app.cochat.ai/papers/10.2337/diabetes.51.2.311
- The paper
- Thomas, H. E., Darwiche, R., Corbett, J. A., & Kay, T. W. H. (2002). Interleukin-1 Plus γ-Interferon-Induced Pancreatic β-Cell Dysfunction Is Mediated by β-Cell Nitric Oxide Production. Diabetes. https://doi.org/10.2337/diabetes.51.2.311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.